ams-OSRAM AG Unsponsored ADR (OTCMKTS:AMSSY – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $7.70, but opened at $8.1460. ams-OSRAM shares last traded at $8.1460, with a volume of 379 shares trading hands.
Analysts Set New Price Targets
AMSSY has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft cut shares of ams-OSRAM to a “hold” rating in a report on Wednesday, February 11th. Zacks Research raised shares of ams-OSRAM from a “strong sell” rating to a “hold” rating in a report on Wednesday, February 11th. Three investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Reduce”.
Get Our Latest Analysis on ams-OSRAM
ams-OSRAM Stock Up 5.8%
ams-OSRAM (OTCMKTS:AMSSY – Get Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.04 by $0.16. ams-OSRAM had a negative net margin of 3.76% and a positive return on equity of 6.11%. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $870.83 million. On average, equities research analysts predict that ams-OSRAM AG Unsponsored ADR will post -0.35 earnings per share for the current year.
ams-OSRAM Company Profile
ams-OSRAM AG is a global technology company specializing in optical solutions, combining the sensor expertise of ams with the lighting heritage of OSRAM. The company develops and manufactures a broad range of high-performance products, including light-emitting diodes (LEDs), laser diode and infrared (IR) emitters, optical sensors, and sensor interfaces. These components are used across a variety of applications to enable advanced illumination, sensing, and imaging capabilities.
The company’s product portfolio serves diverse end markets such as consumer electronics, automotive, industrial, and medical.
See Also
Receive News & Ratings for ams-OSRAM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ams-OSRAM and related companies with MarketBeat.com's FREE daily email newsletter.
